StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$920.69−2.65 (-0.29%)

Close on Nov 20, 2026Market cap $95.24BP/E 20.3Yield –

Regeneron Pharmaceuticals Libtayo by Quarter

Libtayo — Global Net Product Sales Recorded by Regeneron ($M) ($M)

Regeneron Pharmaceuticals Libtayo: $550M in Q3 2026, up 50.6% from a year earlier. That is the highest of the 15 quarters on record here.

Latest, Q3 2026
550
Period ended Sep 30, 2026
Change on a year earlier
+50.6%
365 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
10
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-30) ↗

Reported in Form 10-Q / 10-K Note — Net Product Sales (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLibtayo — Global Net Product Sales Recorded by Regeneron ($M) ($M)Year on yearSource
Q3 2026Sep 30, 2026550+50.6%Form 10-Q (filed 2026-10-30) ↗
Q2 2026Jun 30, 2026489+30.0%Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 2026438+53.7%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025425+15.9%Form 10-K (filed 2026-02-04) ↗
Q3 2025Sep 30, 2025365+26.5%Form 10-Q (filed 2026-10-30) ↗
Q2 2025Jun 30, 2025377+26.6%Form 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 2025285+8.0%Form 10-Q (filed 2026-04-29) ↗
Q4 2024Dec 31, 2024367+50.5%Form 10-K (filed 2026-02-04) ↗
Q3 2024Sep 30, 2024289+24.2%Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 2024297+41.6%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 2024264+49.2%Form 10-Q (filed 2025-04-29) ↗
Q4 2023Dec 31, 2023244–Form 10-K (filed 2026-02-04) ↗
Q3 2023Sep 30, 2023232–Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 2023210–Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 2023177–Form 10-Q (filed 2024-05-02) ↗

Breakdown

What makes up libtayo

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Libtayo ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-libtayo-ww

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?